Edward Michna, J.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 25 | 2017 | 3674 | 1.700 |
Why?
|
| Oxycodone | 4 | 2014 | 153 | 1.290 |
Why?
|
| Pain | 13 | 2015 | 4986 | 0.920 |
Why?
|
| Naltrexone | 3 | 2017 | 307 | 0.790 |
Why?
|
| Constipation | 4 | 2017 | 546 | 0.750 |
Why?
|
| Opioid-Related Disorders | 11 | 2015 | 2065 | 0.730 |
Why?
|
| Narcotic Antagonists | 3 | 2017 | 562 | 0.670 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2014 | 281 | 0.560 |
Why?
|
| Analgesics, Non-Narcotic | 4 | 2014 | 365 | 0.540 |
Why?
|
| Oxymorphone | 1 | 2014 | 7 | 0.490 |
Why?
|
| Technology, Pharmaceutical | 1 | 2014 | 84 | 0.480 |
Why?
|
| Acetaminophen | 3 | 2014 | 545 | 0.430 |
Why?
|
| Narcotics | 1 | 2013 | 343 | 0.390 |
Why?
|
| Product Recalls and Withdrawals | 1 | 2010 | 7 | 0.370 |
Why?
|
| Delayed-Action Preparations | 4 | 2014 | 968 | 0.370 |
Why?
|
| Defecation | 1 | 2011 | 188 | 0.350 |
Why?
|
| Malpractice | 4 | 2016 | 572 | 0.320 |
Why?
|
| Health Resources | 1 | 2014 | 911 | 0.310 |
Why?
|
| Hydrocodone | 4 | 2015 | 47 | 0.310 |
Why?
|
| Cost of Illness | 2 | 2014 | 1859 | 0.290 |
Why?
|
| Insurance, Liability | 3 | 2016 | 102 | 0.280 |
Why?
|
| Health Care Costs | 2 | 2014 | 3209 | 0.240 |
Why?
|
| Insurance Claim Review | 4 | 2016 | 720 | 0.220 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2017 | 205 | 0.220 |
Why?
|
| Medical History Taking | 1 | 2004 | 783 | 0.190 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2014 | 3022 | 0.180 |
Why?
|
| Electric Stimulation Therapy | 2 | 2016 | 605 | 0.180 |
Why?
|
| Pain Threshold | 2 | 2016 | 584 | 0.180 |
Why?
|
| Back Pain | 2 | 2016 | 545 | 0.170 |
Why?
|
| Models, Neurological | 1 | 2007 | 1774 | 0.170 |
Why?
|
| Infusion Pumps, Implantable | 2 | 2016 | 156 | 0.170 |
Why?
|
| Behavior, Addictive | 1 | 2004 | 462 | 0.160 |
Why?
|
| Pain Measurement | 9 | 2016 | 3420 | 0.160 |
Why?
|
| Cost Savings | 2 | 2014 | 926 | 0.160 |
Why?
|
| Pharmaceutical Preparations | 1 | 2007 | 1071 | 0.160 |
Why?
|
| Low Back Pain | 3 | 2015 | 956 | 0.150 |
Why?
|
| Double-Blind Method | 9 | 2015 | 12026 | 0.140 |
Why?
|
| Conscious Sedation | 3 | 2006 | 528 | 0.140 |
Why?
|
| Injections, Spinal | 1 | 2015 | 303 | 0.130 |
Why?
|
| Injections, Subcutaneous | 2 | 2017 | 666 | 0.120 |
Why?
|
| United States Food and Drug Administration | 2 | 2014 | 1584 | 0.120 |
Why?
|
| Criminal Law | 1 | 2014 | 96 | 0.120 |
Why?
|
| Chronic Disease | 9 | 2011 | 9146 | 0.120 |
Why?
|
| Substance-Related Disorders | 2 | 2013 | 4258 | 0.110 |
Why?
|
| Headache Disorders, Secondary | 1 | 2013 | 36 | 0.110 |
Why?
|
| Middle Aged | 27 | 2017 | 213383 | 0.110 |
Why?
|
| Adult | 23 | 2017 | 214055 | 0.110 |
Why?
|
| Drug Tolerance | 1 | 2014 | 376 | 0.110 |
Why?
|
| Absenteeism | 1 | 2014 | 250 | 0.110 |
Why?
|
| Drug Labeling | 1 | 2014 | 233 | 0.100 |
Why?
|
| Peripheral Nerves | 1 | 2015 | 466 | 0.100 |
Why?
|
| Drug Combinations | 3 | 2014 | 1959 | 0.100 |
Why?
|
| Needlestick Injuries | 1 | 2011 | 67 | 0.100 |
Why?
|
| Psychotropic Drugs | 2 | 2014 | 894 | 0.090 |
Why?
|
| Nausea | 1 | 2013 | 673 | 0.090 |
Why?
|
| Male | 30 | 2017 | 350118 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2011 | 426 | 0.090 |
Why?
|
| Neck Pain | 1 | 2011 | 180 | 0.090 |
Why?
|
| Female | 31 | 2017 | 380194 | 0.090 |
Why?
|
| Pentobarbital | 2 | 2006 | 155 | 0.090 |
Why?
|
| Affective Symptoms | 1 | 2012 | 407 | 0.090 |
Why?
|
| Health Services | 1 | 2014 | 758 | 0.080 |
Why?
|
| Analgesics | 1 | 2015 | 1040 | 0.080 |
Why?
|
| Liver Failure, Acute | 1 | 2010 | 165 | 0.080 |
Why?
|
| United States | 8 | 2014 | 69872 | 0.080 |
Why?
|
| Treatment Outcome | 10 | 2016 | 63114 | 0.080 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2007 | 50 | 0.080 |
Why?
|
| Humans | 36 | 2017 | 744343 | 0.080 |
Why?
|
| Morphine | 2 | 2014 | 657 | 0.080 |
Why?
|
| Hydromorphone | 1 | 2007 | 65 | 0.070 |
Why?
|
| Placebos | 1 | 2011 | 1676 | 0.070 |
Why?
|
| Drug Costs | 1 | 2014 | 1105 | 0.070 |
Why?
|
| Cross-Over Studies | 4 | 2015 | 2029 | 0.070 |
Why?
|
| Patient Compliance | 3 | 2012 | 2684 | 0.070 |
Why?
|
| Research | 1 | 2014 | 1999 | 0.070 |
Why?
|
| Urinalysis | 1 | 2007 | 369 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2007 | 283 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3508 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2012 | 1058 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2013 | 1643 | 0.060 |
Why?
|
| Crime | 1 | 2004 | 215 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 931 | 0.060 |
Why?
|
| Aged | 13 | 2017 | 163280 | 0.050 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2015 | 295 | 0.050 |
Why?
|
| Anesthesia, General | 2 | 2015 | 1171 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2014 | 2348 | 0.050 |
Why?
|
| Medicaid | 1 | 2014 | 2736 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2282 | 0.040 |
Why?
|
| Anesthesia | 1 | 2011 | 1561 | 0.040 |
Why?
|
| Sclerotherapy | 1 | 2000 | 175 | 0.040 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2000 | 129 | 0.040 |
Why?
|
| Family Health | 1 | 2004 | 1282 | 0.040 |
Why?
|
| Respiration | 1 | 2005 | 1653 | 0.040 |
Why?
|
| Adolescent | 5 | 2014 | 85781 | 0.040 |
Why?
|
| Radiology, Interventional | 1 | 2002 | 460 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2006 | 1162 | 0.040 |
Why?
|
| Research Design | 2 | 2012 | 5987 | 0.040 |
Why?
|
| Databases, Factual | 4 | 2015 | 7729 | 0.040 |
Why?
|
| Cardiovascular System | 1 | 2005 | 832 | 0.040 |
Why?
|
| Pain, Intractable | 1 | 1998 | 130 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7913 | 0.040 |
Why?
|
| Arteriovenous Malformations | 1 | 2000 | 396 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2016 | 3913 | 0.040 |
Why?
|
| Young Adult | 5 | 2014 | 56430 | 0.040 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 1998 | 161 | 0.040 |
Why?
|
| Ketamine | 1 | 2002 | 500 | 0.040 |
Why?
|
| Medicare | 1 | 2014 | 6566 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2015 | 6600 | 0.030 |
Why?
|
| Time | 1 | 2017 | 542 | 0.030 |
Why?
|
| Tablets | 1 | 2015 | 145 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2012 | 7279 | 0.030 |
Why?
|
| Muscle Spasticity | 1 | 2015 | 154 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1998 | 977 | 0.030 |
Why?
|
| Urination Disorders | 1 | 2015 | 241 | 0.030 |
Why?
|
| Ethanol | 1 | 2000 | 1342 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2015 | 40561 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2014 | 10943 | 0.030 |
Why?
|
| Phytotherapy | 1 | 2014 | 298 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2006 | 6150 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 2886 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2005 | 3507 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1998 | 1387 | 0.020 |
Why?
|
| Hospitalization | 1 | 2010 | 10262 | 0.020 |
Why?
|
| Marijuana Smoking | 1 | 2014 | 253 | 0.020 |
Why?
|
| Anesthesiology | 2 | 2011 | 1060 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2010 | 235 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18370 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15076 | 0.020 |
Why?
|
| Drug Users | 1 | 2010 | 134 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4933 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2008 | 919 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 588 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 1413 | 0.020 |
Why?
|
| Chloral Hydrate | 1 | 2005 | 29 | 0.020 |
Why?
|
| Mood Disorders | 1 | 2012 | 1106 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 2011 | 975 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2016 | 53288 | 0.020 |
Why?
|
| Risk-Taking | 1 | 2010 | 986 | 0.020 |
Why?
|
| Risk Factors | 4 | 2012 | 72290 | 0.010 |
Why?
|
| Midazolam | 1 | 2005 | 270 | 0.010 |
Why?
|
| Organization and Administration | 1 | 2002 | 52 | 0.010 |
Why?
|
| Fentanyl | 1 | 2005 | 410 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2010 | 1827 | 0.010 |
Why?
|
| Nursing Assessment | 1 | 2002 | 107 | 0.010 |
Why?
|
| Credentialing | 1 | 2002 | 126 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2012 | 1637 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 57776 | 0.010 |
Why?
|
| Pediatric Nursing | 1 | 2002 | 103 | 0.010 |
Why?
|
| Child, Preschool | 4 | 2006 | 41006 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 552 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2007 | 77449 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10388 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 26385 | 0.010 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2002 | 469 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3743 | 0.010 |
Why?
|
| ROC Curve | 1 | 2006 | 3527 | 0.010 |
Why?
|
| Radiology Department, Hospital | 1 | 2002 | 412 | 0.010 |
Why?
|
| Radiography, Interventional | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Anxiety | 1 | 2012 | 4297 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2274 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2000 | 1005 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 13989 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2005 | 1886 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2012 | 9959 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 12804 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2010 | 4468 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2006 | 20129 | 0.010 |
Why?
|
| Depression | 1 | 2012 | 7766 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14722 | 0.010 |
Why?
|
| Child | 3 | 2006 | 77709 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2002 | 2531 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 13408 | 0.010 |
Why?
|
| Prevalence | 1 | 2007 | 15226 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1998 | 1809 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 25043 | 0.010 |
Why?
|
| Linear Models | 1 | 2000 | 5952 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 40075 | 0.010 |
Why?
|
| Infant | 2 | 2002 | 35136 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 19905 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2006 | 35421 | 0.010 |
Why?
|